These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10763140)

  • 1. Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
    Raigoso P; Junco A; Andicoechea A; Gonzalez A; García-Muñiz JL; Allende MT; García-Morán M; Vizoso F
    Int J Biol Markers; 2000; 15(1):44-50. PubMed ID: 10763140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
    Vizoso F; Villar C; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Moran M
    Int J Surg Investig; 2000; 1(6):483-93. PubMed ID: 11729856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors.
    Vizoso FJ; Fagilde MC; Corte MD; Corte MG; Gava R; Bongera M; Allende MT; García-Muñiz JL
    Int J Biol Markers; 2003; 18(4):301-10. PubMed ID: 14756547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tissue-type plasminogen activator (tPA) content in gastric cancer and surrounding mucosa.
    Sanz L; Vizoso F; Vérez P; Allende MT; Corte MG; Abdel-Lah O; Martín A; García-Muñíz JL
    Int J Biol Markers; 2002; 17(3):169-76. PubMed ID: 12408467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
    Ganesh S; Sier CF; Heerding MM; van Krieken JH; Griffioen G; Welvaart K; van de Velde CJ; Verheijen JH; Lamers CB; Verspaget HW
    Br J Cancer; 1997; 75(12):1793-801. PubMed ID: 9192984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44s expression in resectable colorectal carcinomas and surrounding mucosa.
    Fernández JC; Vizoso FJ; Corte MD; Gava RR; Corte MG; Suárez JP; García-Muñíz JL; García-Morán M
    Cancer Invest; 2004; 22(6):878-85. PubMed ID: 15641486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
    Ganesh S; Sier CF; Griffioen G; Vloedgraven HJ; de Boer A; Welvaart K; van de Velde CJ; van Krieken JH; Verheijen JH; Lamers CB
    Cancer Res; 1994 Aug; 54(15):4065-71. PubMed ID: 8033138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cysteine and serine proteases in colorectal carcinoma.
    Herszènyi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Cardin R; Tulassay Z; Naccarato R; Farinati F
    Cancer; 1999 Oct; 86(7):1135-42. PubMed ID: 10506696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D content in colorectal cancer. Correlation with cathepsin D activity and other biological parameters: a preliminary report.
    Tumminello FM; Gebbia N; Pizzolanti G; Russo A; Bazan V; Leto G
    Oncology; 1995; 52(3):237-42. PubMed ID: 7715907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness.
    Buø L; Meling GI; Karlsrud TS; Johansen HT; Aasen AO
    Hum Pathol; 1995 Oct; 26(10):1133-8. PubMed ID: 7557947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance.
    Corte MD; Vérez P; Rodríguez JC; Roibás A; Domínguez ML; Lamelas ML; Vázquez J; García Muñiz JL; Allende MT; González LO; Fueyo A; Vizoso F
    Breast Cancer Res Treat; 2005 Mar; 90(1):33-40. PubMed ID: 15770524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid as prognostic marker in resectable colorectal cancer.
    Llaneza A; Vizoso F; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Morán M
    Br J Surg; 2000 Dec; 87(12):1690-6. PubMed ID: 11122186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in colorectal cancer and surrounding mucosa.
    Raigoso P; Sanz L; Vizoso F; Llana B; Quintela ; Roibás A; Vérez P; García-Muñiz IL
    Int J Biol Markers; 2001; 16(4):262-7. PubMed ID: 11820722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results.
    Di Leo A; Messa C; Russo F; Misciagna G; Guerra V; Taveri R; Leo S
    Dig Dis Sci; 1994 Sep; 39(9):2038-42. PubMed ID: 8082515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
    Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
    Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
    Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
    J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer.
    de Witte JH; Sweep CG; Klijn JG; Grebenschikov N; Peters HA; Look MP; van Tienoven TH; Heuvel JJ; Bolt-De Vries J; Benraad TJ; Foekens JA
    Br J Cancer; 1999 Apr; 80(1-2):286-94. PubMed ID: 10390010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study.
    Tomoda H; Kakeji Y; Furusawa M
    J Surg Oncol; 1993 Jul; 53(3):144-8. PubMed ID: 8331935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
    Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
    Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.